Variability and Power to Detect Progression of Different Visual Field Patterns.
Fernanda N Susanna, Bruna Melchior, Jayter S Paula, Michael V Boland, Jonathan S Myers, Sarah R Wellik, Tobias Elze, Louis R Pasquale, Lucy Q Shen, Robert Ritch, Remo Susanna, Donald C Hood, Jeffrey M Liebmann, Moraes Carlos Gustavo De
Summary
Time to detect central VF progression was reduced with 10-2 MD compared with 24-2 and C24-2 MD in glaucoma eyes in this large dataset, in part because 10-2 tests had lower variability.
Abstract
PURPOSE
To compare the variability and ability to detect visual field (VF) progression of 24-2, central 12 locations of the 24-2 and 10-2 VF tests in eyes with abnormal VFs.
DESIGN
Retrospective, multisite cohort.
PARTICIPANTS
A total of 52 806 24-2 and 11 966 10-2 VF tests from 7307 eyes from the Glaucoma Research Network database were analyzed. Only eyes with ≥ 5 visits and ≥ 2 years of follow-up were included.
METHODS
Linear regression models were used to calculate the rates of mean deviation (MD) change (slopes), whereas their residuals were used to assess variability across the entire MD range. Computer simulations (n = 10 000) based on real MD residuals of our sample were performed to estimate power to detect significant progression (P < 5%) at various rates of MD change.
MAIN OUTCOME MEASURES
Time required to detect progression.
RESULTS
For all 3 patterns, the MD variability was highest within the -5 to -20 decibel (dB) range and consistently lower with the 10-2 compared with 24-2 or central 24-2. Overall, time to detect confirmed significant progression at 80% power was the lowest with 10-2 VF, with a decrease of 14.6% to 18.5% when compared with 24-2 and a decrease of 22.9% to 26.5% when compared with central 24-2.
CONCLUSIONS
Time to detect central VF progression was reduced with 10-2 MD compared with 24-2 and C24-2 MD in glaucoma eyes in this large dataset, in part because 10-2 tests had lower variability. These findings contribute to current evidence of the potential value of 10-2 testing in the clinical management of patients with glaucoma and in clinical trial design.
Keywords
More by Fernanda N Susanna
View full profile →Patterns of Visual Field Loss in Early, Moderate, and Severe Stages of Open Angle Glaucoma.
Comparison of Intraocular Pressure Changes During the Water Drinking Test Between Different Fluid Volumes in Patients With Primary Open-angle Glaucoma.
Efficacy and Safety of the Susanna Glaucoma Drainage Device After 1 Year of Follow-up.
Top Research in Visual Field
Browse all →Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.
Relationship between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma.
Improving our understanding, and detection, of glaucomatous damage: An approach based upon optical coherence tomography (OCT).
Discussion
Comments and discussion will appear here in a future update.